HealthCor Catalio Acquisition today registered with the SEC to offer 15 million units at $10 each for a $150 million IPO.
The SPAC will focus on the healthcare industry in the United States and other developed countries, particularly the life sciences and medical technology sectors.
Healthcor is led by CEO Christopher Gaulin, who joined HealthCor in 2018 from Soros Fund Management where he managed the firm’s healthcare equity investments.
HealthCor intends to list on the Nasdaq under HCAQU. Read more.
